Craft

Amgen

Stock Price

$265.4

2023-11-17

Market Capitalization

$142 B

2023-11-17

Revenue

$26.3 B

FY, 2022

Amgen Summary

Company Summary

Overview
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics. It focuses on oncology and hematology, cardiovascular disease, inflammation, bone health, nephrology, and neuroscience. Its major brands include Aimovig, Aranesp, BLINCYTO, Corlanor, KYPROLIS, EVENITY, and NEUPOGEN.
Type
Public
Status
Active
Founded
1980
HQ
Thousand Oaks, CA, US | view all locations
Website
https://www.amgen.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Robert A. Bradway

    Robert A. Bradway, Chairman and Chief Executive Officer

  • Mike Zahigian

    Mike Zahigian, Senior Vice President and Chief Information Officer

  • Darryl Sleep

    Darryl Sleep, Senior Vice President, Global Medical and Chief Medical Officer

  • Jackie Elbonne

    Jackie Elbonne, Senior Vice President, Quality and Chief Quality Officer

Operating MetricsView all

Distribution Centers (Foreign)

3

FY, 2020

Countries

100

FY, 2020

Patents (US)

31
8.8%

FY, 2020

LocationsView all

65 locations detected

  • Thousand Oaks, CA HQ

    United States

    1 Amgen Center Dr

  • Cambridge, MA

    United States

    360 Binney St

  • Louisville, KY

    United States

    12000 Plantside Dr

  • South San Francisco, CA

    United States

    1120 Veterans Blvd

  • Tampa, FL

    United States

    2202 N Westshore Blvd

  • Washington, DC

    United States

    601 13th St NW 12th Floor

and 59 others

Amgen Financials

Summary Financials

Revenue (Q3, 2023)
$6.9B
Gross profit (Q3, 2023)
$5.1B
Net income (Q3, 2023)
$1.7B
Cash (Q3, 2023)
$34.7B
EBIT (Q3, 2023)
$2.0B
Enterprise value
$167.8B

Footer menu